TrialRestorative neurology and neuroscience2020

A double-blind, randomized, controlled study of two dose strengths of dalfampridine extended release on walking deficits in ischemic stroke.

Stephen J Page et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.